Limor Rozen files Form 144 to sell shares

Limor Rozen has filed a Form 144 to sell additional shares of issuer IINN.

Accepted by SEC EDGAR 01/16/2026 - 10:49 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Limor Rozen has filed a Form 144 to sell additional shares of issuer IINN. The notice covers 4,701 ordinary shares to be sold through Oppenheimer & Co. Inc. on NASDAQ, with an aggregate market value of $4,183.89. The filing notes that 24,252,096 ordinary shares were outstanding at the time of the notice.

The 4,701 shares to be sold were acquired on 11/01/2020 through an employee stock option plan and are to be paid for in cash upon exercise on 01/15/2026. The form also reports that during the past three months, Limor Rozen sold 14,999 ordinary shares on 10/22/2025 for gross proceeds of $15,898.94 and 10,730 ordinary shares on 11/12/2025 for gross proceeds of $10,856.61.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for IINN disclose?

It discloses that shareholder Limor Rozen plans to sell 4,701 ordinary shares of IINN, with an aggregate market value of $4,183.89, on NASDAQ.

Who is selling IINN shares and through which broker?

The filer is Limor Rozen, who plans to sell ordinary shares of IINN through Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004.

How many IINN shares are covered by this planned sale and when?

The notice covers 4,701 ordinary shares, with an approximate sale date of 01/15/2026 on the NASDAQ exchange.

How and when were the IINN shares to be sold acquired?

The 4,701 ordinary shares were acquired on 11/01/2020 via an employee stock options plan from the issuer, with cash upon exercise scheduled for 01/15/2026.

What IINN share sales has Limor Rozen made in the past 3 months?

In the past three months, Limor Rozen sold 14,999 ordinary shares on 10/22/2025 for $15,898.94 and 10,730 ordinary shares on 11/12/2025 for $10,856.61.

How many IINN shares were outstanding when this Form 144 was filed?

The filing states that 24,252,096 ordinary shares of the issuer were outstanding at the time of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002077356
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Inspira Technologies OXY B.H.N. Ltd
SEC File Number	001-40303
Address of Issuer	HATIDHAR 2 11TH FLOOR RA'ANANA ISRAEL 4366504
Phone	972-9-9664488
Name of Person for Whose Account the Securities are To Be Sold	Rozen Limor
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	4701	4183.89	24252096	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	11/01/2020	Employee Stock Options plan	Issuer			4701	01/15/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Limor Rozen HATIDHAR 2 11TH FLOOR RA'ANANA L3 4366504	Ordinary	10/22/2025	14999	15898.94
Limor Rozen HATIDHAR 2 11TH FLOOR RA'ANANA L3 4366504	Ordinary	11/12/2025	10730	10856.61

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Limor Rozen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)